Omnicell to Acquire Aesynt for $275 Million

Mountain View, Calif.-based Omnicell has reached an agreement to acquire Aesynt, a medication management company, for about $275 million.

The acquisition will broaden the Omnicell’s existing portfolio with Aesynt’s IV solutions, central pharmacy solutions, point of care solutions and enterprise software.

Specific products from Aesynt include IV preparation analytics, unit dose medication dispensing robots, medication storage and dispensing cabinets for nursing units and operating rooms, and medication logistics management software.

The transaction is expected to close in 2016. — Michael Cipriano